Decision X/6: Essential-use nominations for non-Article 5 Parties for controlled substances for 1999 and 2000
The Tenth Meeting of the Parties decided in Dec. X/6:
- To note with appreciation the excellent work done by the Technology and Economic Assessment Panel and its technical options committees;
- That the levels of production and consumption necessary to satisfy essential uses of CFC-11, CFC-12, CFC-113 and CFC-114, for metered-dose inhalers for asthma and chronic obstructive pulmonary diseases, CFC-113 for use in the coating of cardiovascular surgical material and halon-2402 for fire protection are authorized as specified in annex I to the report of the Tenth Meeting of the Parties, subject to the conditions established by the Meeting of the Parties in paragraph 2 of its decision VII/28;
- To agree that the remaining quantity of methyl chloroform authorized for the United States at previous meetings of the Parties be made available for use in manufacturing solid rocket motors until such time as the 1999-2001 quantity of 176.4 tonnes (17.6 ODP-weighted tonnes) allowance is depleted, or until such time as safe alternatives are implemented for remaining essential uses;
- To approve the authorization by the Secretariat in consultation with the Technology and Economic Assessment Panel of the emergency uses of 1.7 tonnes of CFC-113 for 1997 and 1998 for torpedo maintenance submitted as an essential-use nomination by Poland;
- That the quantities approved under paragraph 2 above and all future approvals are for total CFC volumes with flexibility between CFCs within each group.